Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies.
Lézot, Frédéric
Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. [electronic resource] - Bone Nov 2014 - 146-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2763
10.1016/j.bone.2014.08.018 doi
Animals
Animals, Newborn
Bone Development--drug effects
Bone Neoplasms--drug therapy
Child
Craniofacial Abnormalities--chemically induced
Diphosphonates--therapeutic use
Female
Humans
Imidazoles--therapeutic use
Mice, Inbred C57BL
Phenotype
Tibia--diagnostic imaging
X-Ray Microtomography
Zoledronic Acid
Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. [electronic resource] - Bone Nov 2014 - 146-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2763
10.1016/j.bone.2014.08.018 doi
Animals
Animals, Newborn
Bone Development--drug effects
Bone Neoplasms--drug therapy
Child
Craniofacial Abnormalities--chemically induced
Diphosphonates--therapeutic use
Female
Humans
Imidazoles--therapeutic use
Mice, Inbred C57BL
Phenotype
Tibia--diagnostic imaging
X-Ray Microtomography
Zoledronic Acid